Zotepine
- Generic Name
- Zotepine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18ClNOS
- CAS Number
- 26615-21-4
- Unique Ingredient Identifier
- U29O83JAZW
- Background
Zotepine, with the formula (2-chloro-11-(2-dimethyl-amino-ethoxy)-dibenzo thiepin, is a neuroleptic drug. It was designed and synthesized by Fujisawa Pharmaceutical Co Ltd. It has been used as an antipsychotic in Japan, India and some places in Europe like UK and Germany since 1980's. Zotepine was never approved by the FDA. In 1993, it was classified as inac...
- Indication
Zotepine, like other atypical antipsychotics, is considered as the first-line treatment in newly diagnosed schizophrenia. It is usually thought to be an option of choice for managing acute schizophrenic episodes when discussion with the patient is not possible. Zotepine, as an atypical antipsychotic, is used in patients who are suffering unacceptable side ef...
- Associated Conditions
- -
- Associated Therapies
- -
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Organon and Co
- Target Recruit Count
- 42
- Registration Number
- NCT01498770
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2010-04-16
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 39
- Registration Number
- NCT00418873
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.